These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 10751572)

  • 21. L-DOPA modulation of corpus striatal dopamine and dihydroxyphenylacetic acid output from intact and 6-OHDA lesioned rats.
    Xu K; Dluzen DE
    J Neural Transm (Vienna); 1996; 103(11):1295-305. PubMed ID: 9013416
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Striatal adenosine A(2A) receptor blockade increases extracellular dopamine release following l-DOPA administration in intact and dopamine-denervated rats.
    Gołembiowska K; Dziubina A
    Neuropharmacology; 2004 Sep; 47(3):414-26. PubMed ID: 15275831
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Microdialysis study of tolcapone effect during blockage of neuronal dopamine reuptake caused by GBR-12909].
    Budygin EA; Gaĭnetdinov RR; Raevskiĭ KS; Li IH; Mannisto PT
    Eksp Klin Farmakol; 1997; 60(5):8-10. PubMed ID: 9483396
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The effect of adenosine A(2A) receptor antagonists on hydroxyl radical, dopamine, and glutamate in the striatum of rats with altered function of VMAT2.
    Gołembiowska K; Dziubina A
    Neurotox Res; 2012 Aug; 22(2):150-7. PubMed ID: 22407500
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Characterization of extracellular dopamine clearance in the medial prefrontal cortex: role of monoamine uptake and monoamine oxidase inhibition.
    Wayment HK; Schenk JO; Sorg BA
    J Neurosci; 2001 Jan; 21(1):35-44. PubMed ID: 11150317
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Possible synergies between isatin, an endogenous MAO inhibitor, and antiparkinsonian agents on the dopamine release from striatum of freely moving rats.
    Faro LRF; Justo LA; Alfonso M; Durán R
    Neuropharmacology; 2020 Jul; 171():108083. PubMed ID: 32304702
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Intracerebral dialysis monitoring of striatal dopamine release and metabolism in response to L-dopa.
    Brannan T; Knott P; Kaufmann H; Leung L; Yahr M
    J Neural Transm; 1989; 75(2):149-57. PubMed ID: 2918307
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The effects of administration of monoamine oxidase-B inhibitors on rat striatal neurone responses to dopamine.
    Berry MD; Scarr E; Zhu MY; Paterson IA; Juorio AV
    Br J Pharmacol; 1994 Dec; 113(4):1159-66. PubMed ID: 7889269
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Inhibition of brain MAO-A and animal behaviour induced by p-hydroxyamphetamine.
    Arai Y; Kim SK; Kinemuchi H; Tadano T; Oyama K; Satoh N; Kisara K
    Brain Res Bull; 1991 Jul; 27(1):81-4. PubMed ID: 1933439
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Influence of selective, reversible inhibitors of monoamine oxidase on the prolonged depletion of striatal dopamine by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in mice.
    Fuller RW; Hemrick-Luecke SK
    Life Sci; 1985 Sep; 37(12):1089-96. PubMed ID: 3875779
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Contribution of dopamine to mitochondrial complex I inhibition and dopaminergic deficits caused by methylenedioxymethamphetamine in mice.
    Barros-Miñones L; Goñi-Allo B; Suquia V; Beitia G; Aguirre N; Puerta E
    Neuropharmacology; 2015 Jun; 93():124-33. PubMed ID: 25666033
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Reserpine pretreatment prevents increases in extracellular striatal dopamine following L-DOPA administration in rats with nigrostriatal denervation.
    Kannari K; Tanaka H; Maeda T; Tomiyama M; Suda T; Matsunaga M
    J Neurochem; 2000 Jan; 74(1):263-9. PubMed ID: 10617128
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Dopaminergic modulation of serotonin metabolism in rat striatum: a study with dopamine uptake inhibitor GBR-12909.
    Sivam SP
    Life Sci; 1995; 56(26):PL467-72. PubMed ID: 7540709
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Striatal L-dopa metabolism studied in vivo in rats with nigrostriatal lesions.
    Brannan T; Bhardwaj A; Martinez-Tica J; Weinberger J; Yahr M
    J Neural Transm Park Dis Dement Sect; 1990; 2(1):15-22. PubMed ID: 2113388
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Manganese increases L-DOPA auto-oxidation in the striatum of the freely moving rat: potential implications to L-DOPA long-term therapy of Parkinson's disease.
    Serra PA; Esposito G; Enrico P; Mura MA; Migheli R; Delogu MR; Miele M; Desole MS; Grella G; Miele E
    Br J Pharmacol; 2000 Jun; 130(4):937-45. PubMed ID: 10864903
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Increased striatal dopamine production from L-DOPA following selective inhibition of monoamine oxidase B by R(+)-N-propargyl-1-aminoindan (rasagiline) in the monkey.
    Finberg JP; Wang J; Bankiewicz K; Harvey-White J; Kopin IJ; Goldstein DS
    J Neural Transm Suppl; 1998; 52():279-85. PubMed ID: 9564628
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Differential sensitivity of dopamine release and clearance to 6-hydroxydopamine lesioning in rat striatum.
    Wang Y; Tang FI; Chiou AL; Wang JY
    Life Sci; 1996; 59(21):1783-92. PubMed ID: 8937505
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Semi-chronic increase in striatal level of 3,4-dihydroxyphenylacetaldehyde does not result in alteration of nigrostriatal dopaminergic neurones.
    Legros H; Janin F; Dourmap N; Bonnet JJ; Costentin J
    J Neurosci Res; 2004 Feb; 75(3):429-35. PubMed ID: 14743456
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Dopamine release in rat striatum after administration of L-dope as studied with in vivo electrochemistry.
    Hefti F; Melamed E
    Brain Res; 1981 Nov; 225(2):333-46. PubMed ID: 7306794
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Selective decrease in extracellular DOPAC concentrations in rat striatum following in vivo dialysis with low concentrations of MPP+.
    Caliguri EJ; Johannessen JN
    Brain Res; 1991 May; 548(1-2):94-9. PubMed ID: 1714336
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.